<p>Apyx Medical Corporation（納斯達克代碼：APYX - 獲取免費報告）週一的盤中交易中股價下跌了 1.8%。該公司的股價最低曾達到 3.73 美元，最後交易價為 3.79 美元。在盤中交易中，共成交 38,540 股，較平均交易量 115,008 股下降了 66%。該股票此前收盤價為 3.86 美元。</p>
<h2>分析師評級變動</h2>
<p>多位股票分析師最近對 APYX 股票發表了評論。Citizens Jmp 將 Apyx Medical 的評級從 “市場表現” 上調至 “跑贏大盤”，並在 11 月 12 日的研究報告中設定了 8.00 美元的目標價。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Apyx Medical 的 “賣出（e+）” 評級。Roth Capital 在週一的研究報告中開始覆蓋 Apyx Medical 股票，給予 “買入” 評級，並設定 6.00 美元的目標價。最後，Wall Street Zen 在 11 月 22 日的研究報告中將 Apyx Medical 的評級上調至 “持有”。兩位股票研究分析師給予該股票 “買入” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，Apyx Medical 目前的共識評級為 “持有”，共識目標價為 7.00 美元。</p>
<p><strong>獲取我們關於 Apyx Medical 的最新股票報告</strong></p>
<h2>Apyx Medical 股價下跌 1.8%</h2>
<p>該公司的 50 日簡單移動平均線為 3.57 美元，200 日簡單移動平均線為 2.59 美元。公司的債務與股本比率為 5.69，流動比率為 4.44，速動比率為 3.61。該公司的市值為 1.4493 億美元，市盈率為-10.53，貝塔值為 1.48。</p>
<p>Apyx Medical（納斯達克代碼：APYX - 獲取免費報告）最近在 11 月 6 日發佈了季度財報。該公司報告每股收益（EPS）為-0.05 美元，超出市場共識預期的-0.10 美元，超出幅度為 0.05 美元。Apyx Medical 的股本回報率為-151.01%，淨利潤率為-30.35%。該公司季度收入為 1288 萬美元，而分析師預期為 1200 萬美元。股票分析師預計 Apyx Medical Corporation 在本年度將發佈-0.68 美元的每股收益。</p>
<h2>機構投資者對 Apyx Medical 的看法</h2>
<p>對沖基金最近對該股票的持倉進行了調整。Citadel Advisors LLC 在第三季度新建了約 28,000 美元的 Apyx Medical 持倉。Fisher Asset Management LLC 在第二季度購買了價值 34,000 美元的 Apyx Medical 新股份。Caprock Group LLC 在第三季度新建了價值 40,000 美元的 Apyx Medical 持倉。Osaic Holdings Inc.在第二季度購買了價值 50,000 美元的 Apyx Medical 新股份。最後，Franklin Resources Inc.在第三季度新建了價值 59,000 美元的 Apyx Medical 持倉。目前，55.33% 的股票由機構投資者和對沖基金持有。</p>
<h2>關於 Apyx Medical</h2>
<p>（獲取免費報告）</p>
<p>Apyx Medical Corporation 是一家能源技術公司，專注於在美國和國際上設計、開發和製造醫療設備。該公司通過兩個部門運營：先進能源和原始設備製造（OEM）。它提供氦等離子發生器，用於在開放和微創手術過程中切割、凝固和消融軟組織。</p>
<h2>精選文章</h2>
<ul>
<li>我們更看好的五隻股票，勝過 Apyx Medical</li>
<li>交易暫停的解釋</li>
<li>ServiceNow 的 70 億美元賭注：恐慌還是機會？</li>
<li>10 只最佳航空公司股票推薦</li>
<li>戴爾和惠普正在漲價——投資者應注意</li>
<li>什麼是股息？購買最佳股息股票</li>
<li>為什麼 DLocal 是 2026 年值得關注的頂級新興市場金融科技股票</li>
</ul>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Apyx Medical 嗎？</h2>
<p>在考慮 Apyx Medical 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦，現在購買，以便在更廣泛的市場注意到之前……而 Apyx Medical 並不在名單上。</p>
<p>雖然 Apyx Medical 目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>查看這五隻股票</p>

APYX

<p>Apyx Medical 的股票在午盤交易中下跌了 1.8%，交易量顯著減少。分析師的評級意見不一：Citizens Jmp 將評級上調至 “跑贏大盤”，目標價為 8 美元；Weiss Ratings 維持 “賣出” 評級；Roth Capital 給予 “買入” 評級，目標價為 6 美元；Wall Street Zen 則上調至 “持有”。共識評級為 “持有”，目標價為 7 美元。機構投資者最近已調整了對該股票的持倉</p>

<p>Apyx Medical Corporation (NASDAQ:APYX - Get Free Report)'s share price fell 1.8% during mid-day trading on Monday . The company traded as low as $3.73 and last traded at $3.79. 38,540 shares traded hands during mid-day trading, a decline of 66% from the average session volume of 115,008 shares. The stock had previously closed at $3.86.</p>
<div class="lb-trans"><p>Apyx Medical Corporation（納斯達克代碼：APYX - 獲取免費報告）週一的盤中交易中股價下跌了 1.8%。該公司的股價最低曾達到 3.73 美元，最後交易價為 3.79 美元。在盤中交易中，共成交 38,540 股，較平均交易量 115,008 股下降了 66%。該股票此前收盤價為 3.86 美元。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>A number of equities analysts recently commented on APYX shares. Citizens Jmp raised shares of Apyx Medical from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $8.00 price target on the stock in a research report on Wednesday, November 12th. Weiss Ratings restated a &#34;sell (e+)&#34; rating on shares of Apyx Medical in a research report on Wednesday, October 8th. Roth Capital started coverage on shares of Apyx Medical in a research report on Monday. They issued a &#34;buy&#34; rating and a $6.00 price target for the company. Finally, Wall Street Zen upgraded Apyx Medical to a &#34;hold&#34; rating in a research note on Saturday, November 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Apyx Medical presently has a consensus rating of &#34;Hold&#34; and a consensus price target of $7.00.</p>
<div class="lb-trans"><p>多位股票分析師最近對 APYX 股票發表了評論。Citizens Jmp 將 Apyx Medical 的評級從 “市場表現” 上調至 “跑贏大盤”，並在 11 月 12 日的研究報告中設定了 8.00 美元的目標價。Weiss Ratings 在 10 月 8 日的研究報告中重申了對 Apyx Medical 的 “賣出（e+）” 評級。Roth Capital 在週一的研究報告中開始覆蓋 Apyx Medical 股票，給予 “買入” 評級，並設定 6.00 美元的目標價。最後，Wall Street Zen 在 11 月 22 日的研究報告中將 Apyx Medical 的評級上調至 “持有”。兩位股票研究分析師給予該股票 “買入” 評級，一位給予 “賣出” 評級。根據 MarketBeat 的數據，Apyx Medical 目前的共識評級為 “持有”，共識目標價為 7.00 美元。</p>
</div><p><strong>Get Our Latest Stock Report on Apyx Medical</strong></p>
<div class="lb-trans"><p><strong>獲取我們關於 Apyx Medical 的最新股票報告</strong></p>
</div><h2>Apyx Medical Trading Down 1.8%</h2>
<div class="lb-trans"><h2>Apyx Medical 股價下跌 1.8%</h2>
</div><p>The firm's 50-day simple moving average is $3.57 and its 200 day simple moving average is $2.59. The company has a debt-to-equity ratio of 5.69, a current ratio of 4.44 and a quick ratio of 3.61. The firm has a market capitalization of $144.93 million, a price-to-earnings ratio of -10.53 and a beta of 1.48.</p>
<div class="lb-trans"><p>該公司的 50 日簡單移動平均線為 3.57 美元，200 日簡單移動平均線為 2.59 美元。公司的債務與股本比率為 5.69，流動比率為 4.44，速動比率為 3.61。該公司的市值為 1.4493 億美元，市盈率為-10.53，貝塔值為 1.48。</p>
</div><p>Apyx Medical (NASDAQ:APYX - Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.10) by $0.05. Apyx Medical had a negative return on equity of 151.01% and a negative net margin of 30.35%.The company had revenue of $12.88 million for the quarter, compared to analyst estimates of $12.00 million. Equities analysts expect that Apyx Medical Corporation will post -0.68 earnings per share for the current year.</p>
<div class="lb-trans"><p>Apyx Medical（納斯達克代碼：APYX - 獲取免費報告）最近在 11 月 6 日發佈了季度財報。該公司報告每股收益（EPS）為-0.05 美元，超出市場共識預期的-0.10 美元，超出幅度為 0.05 美元。Apyx Medical 的股本回報率為-151.01%，淨利潤率為-30.35%。該公司季度收入為 1288 萬美元，而分析師預期為 1200 萬美元。股票分析師預計 Apyx Medical Corporation 在本年度將發佈-0.68 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Apyx Medical</h2>
<div class="lb-trans"><h2>機構投資者對 Apyx Medical 的看法</h2>
</div><p>Hedge funds have recently made changes to their positions in the stock. Citadel Advisors LLC acquired a new position in Apyx Medical during the 3rd quarter worth approximately $28,000. Fisher Asset Management LLC bought a new stake in shares of Apyx Medical during the second quarter worth $34,000. Caprock Group LLC acquired a new position in shares of Apyx Medical during the third quarter worth $40,000. Osaic Holdings Inc. bought a new position in shares of Apyx Medical in the 2nd quarter valued at $50,000. Finally, Franklin Resources Inc. acquired a new stake in shares of Apyx Medical during the 3rd quarter valued at $59,000. 55.33% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>對沖基金最近對該股票的持倉進行了調整。Citadel Advisors LLC 在第三季度新建了約 28,000 美元的 Apyx Medical 持倉。Fisher Asset Management LLC 在第二季度購買了價值 34,000 美元的 Apyx Medical 新股份。Caprock Group LLC 在第三季度新建了價值 40,000 美元的 Apyx Medical 持倉。Osaic Holdings Inc.在第二季度購買了價值 50,000 美元的 Apyx Medical 新股份。最後，Franklin Resources Inc.在第三季度新建了價值 59,000 美元的 Apyx Medical 持倉。目前，55.33% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>About Apyx Medical</h2>
<div class="lb-trans"><h2>關於 Apyx Medical</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.</p>
<div class="lb-trans"><p>Apyx Medical Corporation 是一家能源技術公司，專注於在美國和國際上設計、開發和製造醫療設備。該公司通過兩個部門運營：先進能源和原始設備製造（OEM）。它提供氦等離子發生器，用於在開放和微創手術過程中切割、凝固和消融軟組織。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Apyx Medical</li>
<li>Trading Halts Explained</li>
<li>ServiceNow’s $7 Billion Gamble: Panic or Opportunity?</li>
<li>10 Best Airline Stocks to Buy</li>
<li>Dell and HP Are Raising Prices—And Investors Should Take Note</li>
<li>What Are Dividends? Buy the Best Dividend Stocks</li>
<li>Why DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票，勝過 Apyx Medical</li>
<li>交易暫停的解釋</li>
<li>ServiceNow 的 70 億美元賭注：恐慌還是機會？</li>
<li>10 只最佳航空公司股票推薦</li>
<li>戴爾和惠普正在漲價——投資者應注意</li>
<li>什麼是股息？購買最佳股息股票</li>
<li>為什麼 DLocal 是 2026 年值得關注的頂級新興市場金融科技股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Apyx Medical Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Apyx Medical 嗎？</h2>
</div><p>Before you consider Apyx Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Apyx Medical 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apyx Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦的股票。MarketBeat 已識別出五隻股票，頂級分析師正在悄悄地向客户推薦，現在購買，以便在更廣泛的市場注意到之前……而 Apyx Medical 並不在名單上。</p>
</div><p>While Apyx Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Apyx Medical 目前在分析師中獲得 “持有” 評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看這五隻股票</p>
</div>

Apyx Medical（NASDAQ:APYX）股價下跌 1.8% - 以下是原因